US Investors Buying an ETF that Tracks the Canadian Marijuana Industry
$MJ, $DEO, $STZ
US investors are buying into an ETF (exchange-traded fund) that tracks the Canadian marijuana industry as the country moves toward legalization and liquor producers show growing interest in selling marijuana.
The US-listed $436-M ETFMG Alternative Harvest ETF, (ticker MJ), has taken in about $22-M in August, putting it on track for the largest monthly inflow since February. That asset growth has been fueled by a 35% rise in the fund’s price since 14 August.
Marijuana stocks have been rising on Canada’s pending legalization of recreational marijuana on 17 October and growing speculation that other industries will buy in too.
A major boost for cannabis shares came 2 weeks ago, when alcohol giant Constellation Brands Inc. (NYSE:STX) invested $3.8-B in Canadian marijuana maker Canopy Growth Corp., the biggest deal yet in the growing industry.
Since the move was announced on 15 August, the BI Canada Cannabis Competitive Peers index has gained more than 30%, including 3.7% Wednesday, 28 August.
“This reinforces the interest among large consumer companies in partnering with cannabis producers,” said 1 industry analyst. “It also signifies the confidence that consumer companies have for the continued rise in consumer demand for legal cannabis-infused beverages in Canada, but also eventually in the US and in international markets.”
Last week, it was reported that the global liquor giant Diageo Plc (NYSE:DEO)is seeking a cannabis partner, raising market speculation over who that may be.
Molson Coors Canada Inc. also announced a joint venture with Hydropothecary Corp. to develop non-alcoholic, cannabis-infused beverages.
However, while the US-listed fund is going strong, a Canada-listed counterpart is not. The Horizons Marijuana Life Sciences Index ETF, ticker HMMJ, is on track for its biggest month of outflows since it began trading in April 2017, with $6.1-M leaving the fund this month, including $5.1-M on Tuesday alone.
Latest posts by Paul Ebeling (see all)
- Time to Buy Risk as US-China Trade Dispute Resolves - February 23, 2019
- Stay Warm, Cold Air Can Be Dangerous - February 23, 2019
- If Marijuana is Medicine So is Jack Daniels - February 23, 2019